Pierre Lapalme's Net Worth

$6.93 Million

Estimate Recalculated Sep 17, 2024 04:55PM EST

Who is Pierre Lapalme?

Pierre Lapalme has an estimated net worth of $6.93 Million. This is based on reported shares across multiple companies, which include FIRST HORIZON PHARMACEUTICAL CORP, BIOMARIN PHARMACEUTICAL INC, and Insys Therapeutics, Inc..

SEC CIK

Pierre Lapalme's CIK is 0001114913

Past Insider Trading and Trends

2006 was Pierre Lapalme's most active year for acquiring shares with 10 total transactions. Pierre Lapalme's most active month to acquire stocks was the month of April. 2008 was Pierre Lapalme's most active year for disposing of shares, totalling 40 transactions. Pierre Lapalme's most active month to dispose stocks was the month of January. 2007 saw Pierre Lapalme paying a total of $643,225.00 for 36,250 shares, this is the most they've acquired in one year. In 2015 Pierre Lapalme cashed out on 40,000 shares for a total of $2,131,400.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SCIELE PHARMA, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$21.08
-$79,050.00
17.23K
May 23
Form 4
—
0
—
—
0
Apr 25
Form 4
+13.14%
2K
$18.41
$36,823.01
17.23K
Mar 17
Form 4
-48.35%
-14.25K
$25.38
-$361,665.00
15.22K
Sep 4
Form 4
+464.11%
24.25K
$13.58
$329,295.25
29.48K
Apr 25 - Apr 25
Form 4
+91.74%
2.5K
$22.20
$55,487.50
5.22K
Jun 15
Form 4
+10.88%
2.5K
$18.83
$47,062.50
25.48K
May 31
Form 4
—
0
$24.40
—
18.79K
Dec 15
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
No matching records found

BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $83.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.65%
1.1K
—
—
31.25K
Jun 10
Form 4
—
0
$60.40
-$1,846,600.00
30.15K
Mar 3
Form 4
+7.49%
2.1K
—
—
30.15K
Jun 4
Form 4
+13.79%
3.4K
—
—
28.05K
May 15
Form 4
—
0
$32.80
-$1,347,944.56
24.65K
Feb 26
Form 4
+16.00%
3.4K
—
—
24.65K
May 8
Form 4
—
0
$22.24
-$550,706.00
21.25K
Feb 28
Form 4
+13.33%
2.5K
—
—
21.25K
May 12
Form 4
—
0
$15.45
-$287,048.50
18.75K
Feb 23 - Feb 24
Form 4
+15.38%
2.5K
—
—
18.75K
May 12
Form 4
+18.18%
2.5K
—
—
16.25K
May 22
Form 4
+22.22%
2.5K
—
—
13.75K
May 12
Form 4
+23.19%
2.4K
$15.30
$36,711.60
12.75K
Dec 3
Form 4
+56.82%
3.75K
—
—
10.35K
Jul 7
Form 4
—
0
—
—
0
May 22
Form 4
-47.51%
-5.97K
$38.43
-$229,614.50
6.6K
Feb 29
Form 4
+90.53%
5.97K
$21.86
-$252,301.01
12.57K
Feb 29
Form 4
—
0
—
—
0
Jun 7
Form 4/A
+46.67%
2.1K
$17.88
$37,556.25
6.6K
Dec 12
Form 4
+46.67%
2.1K
$17.88
$37,556.25
6.6K
Dec 12
Form 4
+28.57%
1K
$15.35
$15,350.00
4.5K
Aug 7
Form 4
∞
3.5K
$12.99
$45,456.00
3.5K
Feb 27
Form 4
—
0
—
—
0
Jan 27
Form 4
—
0
—
—
0
Jan 27
Form 4
—
0
—
—
0
Jan 27
Form 3
—
0
—
—
0
No matching records found

Insys Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+201.38%
12.08K
—
—
18.08K
Mar 5 - Mar 4
Form 4
+201.38%
12.08K
—
—
18.08K
Mar 5 - Mar 4
Form 4
+200.00%
4K
—
—
6K
Feb 21
Form 4
—
0
—
—
0
Feb 21
Form 4
—
0
—
—
0
May 2
Form 4
—
0
—
—
0
May 5
Form 4
—
0
—
—
0
Aug 7
Form 4
∞
3K
$10.39
$31,170.30
3K
May 24
Form 4
—
0
—
—
0
May 14
Form 3
—
0
—
—
0
No matching records found